天津梅花生物医药科技有限公司

Tianjin Meihua Biological Medicine Technology Co., Ltd. is a specialized subsidiary of Meihua Holdings Group, a global leader in amino acid production through biological fermentation. The company focuses on the research, development, and manufacturing of pharmaceutical-grade amino acids, active pharmaceutical ingredients (APIs), and advanced intermediates. Its product portfolio is essential for clinical nutrition, parenteral infusion, and the synthesis of complex therapeutic agents. Based in the Tianjin Economic-Technological Development Area, the firm leverages the parent group's large-scale fermentation infrastructure to provide high-purity biological products to global markets. It serves as a strategic hub for the group's expansion into the high-value life sciences and healthcare sectors.